5Jemal A,Bray F,Center M M,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
6Chen G,Kronenberger P,Teugels E,et al.Targeting the epidermal growth factor receptor in non-small cell lung cancer cells:the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab[J].BMC Medicine,2012,10(6):28-32.
7Petris L D,CrinòL,Scagliotti G V,et al.Treatment of advanced non-small cell lung cancer[J].Ann Oncol,2006,17(2):36-41.
8Yuan Y,Tan C,Li M,et al.Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib[J].World Journal of Surgical Oncology,2012,10(3):235-243.
9Choi H,Charnsangavej C,de Castro Faria S,et al.CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment:a quantitative analysis correlated with FDG PET findings[J].Am J Roentgenol,2004,183(6):1619-1628.
10Eisenhauer E A,Therasse P,Bogaerts J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline(version 1.1)[J].Eur J Cancer,2009,45(2):228-247.
